Table 1.
Characteristics of non-diabetic MESA participants with eGFR > 60 ml/min/1.73m2 at baseline by body mass index.
| Characteristics | Body mass index (kg/m2) | |||
|---|---|---|---|---|
| <25 | 25.0 – 29.9 | 30.0 – 34.9 | ≥35.0 | |
| N | 1397 | 1826 | 891 | 459 |
| Age (years) | 60 (10) | 61 (10) | 59 (9) | 58 (9) |
| Men | 615 (44%) | 986 (54%) | 444 (50%) | 118 (26%) |
| Race | ||||
| White | 635 (46%) | 755 (41%) | 335 (38%) | 150 (33%) |
| Chinese | 362 (26%) | 161 (9%) | 19 (2%) | 2 (0.4%) |
| Black | 228 (16%) | 463 (25%) | 297 (33%) | 198 (43%) |
| Hispanic | 172 (12%) | 447 (25%) | 240 (27%) | 109 (24%) |
| Waist circumference (cm) | ||||
| Female | 81 (8) | 94 (8) | 105 (9) | 120 (13) |
| Male | 87 (7) | 98 (6) | 109 (6) | 124 (8) |
| Waist to hip circumference ratio | ||||
| Female | 0.85 (0.08) | 0.89 (0.08) | 0.92 (0.07) | 0.94 (0.08) |
| Male | 0.91 (0.06) | 0.96 (0.06) | 0.98 (0.05) | 1.01 (0.05) |
| Total cholesterol (mg/dL) | 195 (33) | 195 (35) | 194 (36) | 195 (34) |
| HDL (mg/dL) | 58 (17) | 50 (13) | 47 (13) | 49 (12) |
| LDL (mg/dL) | 116 (31) | 119 (31) | 118 (30) | 120 (30) |
| Lipid-lowering medications | 126 (9%) | 295 (16%) | 127 (14%) | 66 (14%) |
| Systolic blood pressure (mmHg) | 119 (21) | 125 (19) | 127 (20) | 130 (21) |
| Diastolic blood pressure (mmHg) | 70 (10) | 73 (10) | 74 (10) | 72 (10) |
| Hypertension | 372 (27%) | 703 (39%) | 406 (46%) | 240 (52%) |
| Hypertension medications | 260 (19%) | 561 (31%) | 324 (36%) | 202 (44%) |
| Smoking | ||||
| Never | 749 (54%) | 887 (49%) | 430 (48%) | 218 (48%) |
| Former | 461 (33%) | 685 (38%) | 337 (38%) | 189 (41%) |
| Current | 183 (13%) | 251 (14%) | 121 (14%) | 51 (11%) |
| eGFRCr at baseline (ml/min/1.73m2) | 82 (12) | 81 (13) | 81 (13) | 83 (14) |
| eGFRCys at baseline (ml/min/1.73m2) | 100 (16) | 96 (16) | 92 (16) | 89 (16) |
| ACR > 30 mg/g | 45 (3%) | 86 (5%) | 64 (7%) | 37 (8%) |